Search for: "Janssen Pharmaceuticals Inc." Results 101 - 120 of 195
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Feb 2016, 11:27 pm
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive… [read post]
22 Mar 2016, 6:12 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
12 Feb 2008, 2:55 pm
PriCara is a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Nov 2015, 11:33 am by Tom Lamb
"] The findings are contrary to data presented [in "New Global Real-World Data from Atrial Fibrillation Studies Confirm the Safety Profile of XARELTO®", a press release from Janssen Pharmaceuticals, Inc.] on the safety of [Xarelto (rivaroxaban)] in 39,052 people with NVAF showed the rates and patterns of major bleeding in routine clinical practice were 2.89 per 100 person-years. [read post]
21 Jul 2021, 12:44 pm by Jon L. Gelman
The manufacturers named in the complaint included Purdue Pharma and its affiliates, as well as members of the Sackler Family (owners of Purdue) and trusts they control; Janssen Pharmaceuticals and its affiliates (including its parent company Johnson & Johnson); Mallinckrodt LLC and its affiliates; Endo Health Solutions and its affiliates; Teva Pharmaceuticals USA, Inc. and its affiliates; and Allergan Finance, LLC and its affiliates. [read post]
23 Oct 2009, 4:12 pm
Teva Pharmaceuticals USA, Inc. and related cases) (2009 U.S. [read post]
7 Oct 2013, 7:12 am
Our next post will discuss the complimentary roles of inside and outside counsel. [1] Dura Pharmaceuticals, Inc. v. [read post]
7 Oct 2013, 7:12 am
Our next post will discuss the complimentary roles of inside and outside counsel. [1] Dura Pharmaceuticals, Inc. v. [read post]
25 Mar 2014, 7:41 pm by FDABlog HPM
At trial against J&J, the State of Arkansas relied heavily on a 2004 Warning Letter issued to Janssen Pharmaceutica, Inc., the J&J unit responsible for marketing Risperdal, an antipsychotic drug. [read post]
17 Nov 2015, 5:07 am by Grimes Teich Anderson LLP
Recent articles in Forbes Magazine and The Wall Street Journal reported that Janssen Pharmaceuticals, Inc., which is a Johnson & Johnson company, has been accused of a failure to warn about the side effect. [read post]
18 Jul 2013, 10:45 am by Bexis
Ortho-McNeil-Janssen Pharmaceuticals, 2013 WL 3480286 (Pa. [read post]
16 Jun 2021, 5:20 am by Searcy Law
To what extent Janssen Pharmaceuticals was aware of the risk of maculopathy and subsequent vision loss is unclear. [read post]
16 Jun 2021, 5:20 am by Searcy Law
To what extent Janssen Pharmaceuticals was aware of the risk of maculopathy and subsequent vision loss is unclear. [read post]
16 Jun 2021, 5:20 am by Searcy Law
To what extent Janssen Pharmaceuticals was aware of the risk of maculopathy and subsequent vision loss is unclear. [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets:  Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
5 Mar 2014, 2:46 pm
Wyeth Pharmaceuticals, Inc., Pennsylvania Supreme Court – propriety of punitive damages where defendant compl [read post]
30 Oct 2018, 4:12 pm by Sabrina I. Pacifici
., and Janssen Pharmaceuticals Inc., among others, seeking damages over the opioid crisis. [read post]
26 Nov 2012, 9:00 am by Federal Trade Commission
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]